371 related articles for article (PubMed ID: 11709452)
21. The European Community Study Group on diagnostic criteria for Sjögren's syndrome. Sensitivity and specificity of tests for ocular and oral involvement in Sjögren's syndrome.
Vitali C; Moutsopoulos HM; Bombardieri S
Ann Rheum Dis; 1994 Oct; 53(10):637-47. PubMed ID: 7979575
[TBL] [Abstract][Full Text] [Related]
22. Sialochemistry for diagnosis of Sjögren's syndrome in xerostomic patients.
Ben-Aryeh H; Spielman A; Szargel R; Gutman D; Scharf J; Nahir M; Scharf Y
Oral Surg Oral Med Oral Pathol; 1981 Nov; 52(5):487-90. PubMed ID: 6946376
[TBL] [Abstract][Full Text] [Related]
23. Correlation between salivary epidermal growth factor levels and refractory intraoral manifestations in patients with Sjögren's syndrome.
Azuma N; Katada Y; Kitano S; Sekiguchi M; Kitano M; Nishioka A; Hashimoto N; Matsui K; Iwasaki T; Sano H
Mod Rheumatol; 2014 Jul; 24(4):626-32. PubMed ID: 24252043
[TBL] [Abstract][Full Text] [Related]
24. Salivary gland ultrasonography: can it be an alternative to sialography as an imaging modality for Sjogren's syndrome?
Takagi Y; Kimura Y; Nakamura H; Sasaki M; Eguchi K; Nakamura T
Ann Rheum Dis; 2010 Jul; 69(7):1321-4. PubMed ID: 20498211
[TBL] [Abstract][Full Text] [Related]
25. Sjögren's syndrome: the diagnostic potential of early oral manifestations preceding hyposalivation/xerostomia.
Mignogna MD; Fedele S; Lo Russo L; Lo Muzio L; Wolff A
J Oral Pathol Med; 2005 Jan; 34(1):1-6. PubMed ID: 15610399
[TBL] [Abstract][Full Text] [Related]
26. [Salivary epidermal growth factor (EGF) in Sjögren's syndrome: association between salivary EGF levels and the severity of intraoral manifestations].
Azuma N; Katada Y; Kitano S; Nishioka A; Sekiguchi M; Kitano M; Hashimoto N; Matsui K; Iwasaki T; Sano H
Nihon Rinsho Meneki Gakkai Kaishi; 2016; 39(1):42-50. PubMed ID: 27181234
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of diagnostic parameters from parotid and submandibular dynamic salivary glands scintigraphy and unstimulated sialometry in Sjögren's syndrome.
Dugonjić S; Stefanović D; Ethurović B; Spasić-Jokić V; Ajdinović B
Hell J Nucl Med; 2014; 17(2):116-22. PubMed ID: 25097897
[TBL] [Abstract][Full Text] [Related]
28. Electrophoretic protein pattern of human parotid saliva in Sjögren's syndrome and sialosis.
Benedek-Spät E; Puskás M; Rajki J
Acta Otolaryngol; 1980; 90(3-4):275-82. PubMed ID: 7468188
[TBL] [Abstract][Full Text] [Related]
29. Identification of parotid salivary biomarkers in Sjogren's syndrome by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry and two-dimensional difference gel electrophoresis.
Ryu OH; Atkinson JC; Hoehn GT; Illei GG; Hart TC
Rheumatology (Oxford); 2006 Sep; 45(9):1077-86. PubMed ID: 16522680
[TBL] [Abstract][Full Text] [Related]
30. The status of lactoferrin and total iron binding capacity of human parotid saliva in Sjögren's syndrome.
Haghighat N; al-Hashimi I
Clin Exp Rheumatol; 2003; 21(4):485-8. PubMed ID: 12942702
[TBL] [Abstract][Full Text] [Related]
31. Clinical assessment and diagnosis of immunologically mediated salivary gland disease in Sjögren's syndrome.
Daniels TE
J Autoimmun; 1989 Aug; 2(4):529-41. PubMed ID: 2789655
[TBL] [Abstract][Full Text] [Related]
32. Effects of the antihypertensive drug captopril on human salivary secretion rate and composition.
Nederfors T; Dahlof C; Ericsson T; Twetman S
Eur J Oral Sci; 1995 Dec; 103(6):351-4. PubMed ID: 8747669
[TBL] [Abstract][Full Text] [Related]
33. Salivary lactoferrin in primary Sjögren's syndrome.
Jezequel N; Depasse F; Jouquan J; Lelong A; Roncin S; Pare G; Pennec YL; Youinou P
Clin Exp Rheumatol; 1989; 7(2):123-5. PubMed ID: 2736823
[TBL] [Abstract][Full Text] [Related]
34. Quantitative salivary gland scintigraphy can distinguish patients with primary Sjøgren's syndrome during the evaluation of sicca symptoms.
Henriksen AM; Nossent HC
Clin Rheumatol; 2007 Nov; 26(11):1837-41. PubMed ID: 17318272
[TBL] [Abstract][Full Text] [Related]
35. The Potential Role for Early Biomarker Testing as Part of a Modern, Multidisciplinary Approach to Sjögren's Syndrome Diagnosis.
Beckman KA; Luchs J; Milner MS; Ambrus JL
Adv Ther; 2017 Apr; 34(4):799-812. PubMed ID: 28283891
[TBL] [Abstract][Full Text] [Related]
36. Biomarker profiles in serum and saliva of experimental Sjögren's syndrome: associations with specific autoimmune manifestations.
Delaleu N; Immervoll H; Cornelius J; Jonsson R
Arthritis Res Ther; 2008; 10(1):R22. PubMed ID: 18289371
[TBL] [Abstract][Full Text] [Related]
37. Possible involvement of oxidative stress in salivary gland of patients with Sjogren's syndrome.
Ryo K; Yamada H; Nakagawa Y; Tai Y; Obara K; Inoue H; Mishima K; Saito I
Pathobiology; 2006; 73(5):252-60. PubMed ID: 17314496
[TBL] [Abstract][Full Text] [Related]
38. Whole saliva and the diagnosis of Sjögren's syndrome: an evaluation of patients who complain of dry mouth and dry eyes. Part 1: Screening tests.
Sreebny L; Zhu WX
Gerodontology; 1996 Jul; 13(1):35-43. PubMed ID: 9452640
[TBL] [Abstract][Full Text] [Related]
39. The oral component of Sjögren's syndrome.
Daniels TE; Silverman S; Michalski JP; Greenspan JS; Sylvester RA; Talal N
Oral Surg Oral Med Oral Pathol; 1975 Jun; 39(6):875-85. PubMed ID: 1055974
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic utility of major salivary gland ultrasonography in primary Sjögren's syndrome.
Hammenfors DS; Brun JG; Jonsson R; Jonsson MV
Clin Exp Rheumatol; 2015; 33(1):56-62. PubMed ID: 25535773
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
